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IMPACT OF MUSCLE TRAUMA ON STEM CELL RECRUITMENT DURING 
POST-NATAL ECTOPIC BONE FORMATION 
 
WILLIAM T. MOORE 
ABSTRACT 
Introduction: 
Trauma to the musculoskeletal system can result in heterotopic ossification, a condition 
where aberrant bone tissue is synthesized and mineralized in the soft tissues of the body.  
Satellite cells expressing Pax7 are the predominant stem cell population found within 
adult skeletal muscle tissues. Once activated by trauma, satellite cells are primarily 
implicated in skeletal muscle regeneration by differentiating towards myocytes.  Previous 
research in the lab has shown that no Pax7 derived cells were seen in either the fracture 
callus or periosteal ectopic bone induced by demineralized bone matrix (DBM).  
Questions however persist whether trauma can activate Pax7 cells to contribute to ectopic 
bone formation and whether muscle trauma will enhance the ability of DBM to induce 
ectopic bone in muscle.  
 
Objectives: 
Identify how muscle trauma effects DBM-induced ectopic bone formation and 
characterize the contribution of the Pax7 satellite cell population in DBM-induced 
ectopic bone formation after muscle trauma.  
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Methods: 
The tamoxifen inducible Pax7tm1(cre/ER2)Gaka/J transgenic mice were crossed with B6.Cg-
Gt(ROSA)26sor<tm14(CAG-tdTomato)Hze>/J  to create Pax7/Ai14 reporter. These 
animals were subsequently crossed with B6,129S7-Rag1tm1Mom/J mice. This created a 
transgenic reporter mouse that allows for the implantation of human DBM. Two 
tamoxifen doses (within 48 hours) were given to the animals approximately 31 days prior 
to surgery. Ectopic bone was induced by surgical implantation of DBM (50 mg) with 0.1 
µg of bone morphogenic protein 2 (BMP-2) on the femoral periosteum or in the skeletal 
muscle tissue of the upper hind limb.  Following implantation, mice received varying 
amounts of blunt force trauma to induce skeletal muscle trauma.  Ectopic bone was then 
evaluated radiologically using plain film and micro-computed tomography, and 
histologically through fluorescence and brightfield microscopy.  Micro-computed 
tomography allowed for the calculation of the ectopic bone volume, as well as the 
creation of 3D renderings of the ectopic bone.  Fluorescence microscopy allowed for the 
visualization of recruited Pax7 positive satellite cells to the DBM-induced ectopic bone.  
Trichrome staining techniques allowed for the visualization and categorization of tissue 
types including skeletal muscle, un-mineralized and mineralized bone, and cartilage. 
 
Results: 
Muscle trauma did not significantly change the volume of ectopic bone that was induced 
by BMP-2 supplemented DBM that was implanted on either the periosteum or in skeletal 
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muscle.  However, the amount of BMP2 that was needed within DBM to induce ectopic 
bone within muscle was greatly decreased with muscle trauma.  Intriguingly, muscle 
trauma resulted in the activation and recruitment of Pax7 positive cells to the DBM-
induced ectopic bone in both periosteal and skeletal muscle implants.   
Conclusions: 
Skeletal muscle trauma does not appear to impact the resulting bone volume of BMP2 
supplemented DBM induced ectopic bone formation. However, the decreased dose of 
BMP-2 that was needed to induce ectopic bone formation within muscle suggests that 
trauma sensitized the stem cell populations that contribute to ectopic bone to BMP 
induction.  The appearance of Pax7 within the newly formed ectopic bone with muscle 
trauma suggests that the muscle trauma effects the plasticity of Pax7 satellite enabling 
them to contribute to ectopic bone formation.  Further research is needed to elucidate the 
molecular mechanism(s), which muscle trauma activates that favor ectopic bone 
formation and promotes the plasticity of Pax7 muscle satellite cells.  These studies 
provide basis for the identification of novel therapeutic targets to treat heterotopic 
ossification.   
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INTRODUCTION 	
Fractures are the most common large organ traumatic injury for humans.  In the 
United States, there are approximately 7.9 million fractures per year, of which 5-10 % 
will result in delayed or non-union (American Academy of Orthopaedic Surgeons, 2000).  
Complications related to delayed or non-union fractures are prolonged treatment and 
rehabilitation with the potential of permanent disability.  The prevalence of fractures 
paired with the risk for negative outcomes places a significant economic and health 
burden on our society.  The annual direct and indirect costs of musculoskeletal disease is 
approximately $213 billion (United States Bone and Joint Initiative, 2014). While there 
are a multitude of methods used to bolster fracture healing including invasive (surgical 
fixation), and non-invasive approaches (biologics), many of these approaches impact only 
certain portions of the healing process and do not result in a substantial overall impact in 
patient outcomes (Einhorn & Gerstenfeld, 2015).  The lack of a true “gold standard” non-
invasive approach for fracture repair also highlights the importance of further 
investigation into the mechanisms and signaling involved in bone development, with the 
hope of uncovering novel targets for non-invasive therapeutics to lessen the health and 
economic burden of musculoskeletal disease in our society. 
 
Endochondral Ossification 
Endochondral ossification is the osteogenic process by which the axial (excluding 
the skull and mandible) and appendicular skeleton develops during embryogenesis, as 
well as how post-natal fracture healing and ectopic bone formation occur.  As shown in 
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Figure 1, mesenchymal progenitor cells are recruited to the future region of bone and 
exhibit a marked increase in Sox9 expression which commits the cells to the chondrocyte 
lineage (Akiyama & Lefebvre, 2011).  Following commitment, these cells condense into 
the shape of the future cartilage template, and initiate chondrogenesis.  As the template 
forms, chondrocytes become trapped within the hyaline cartilage matrix.  These trapped 
chondrocytes become hypertrophic and ultimately undergo apoptosis or transdifferentiate 
to osteoblasts (Marcucio, Hu, Yang, Bahney, & Miclau, 2016).  Hypertrophic 
chondrocytes express high levels of vascular epithelial growth factor A, causing the 
formation and invasion of blood vessels into the cartilage template (Gerber et al., 1999).  
This vascular invasion is followed by osteoclasts and osteoblast precursors.  Osteoclasts 
proceed to degrade the cartilage matrix leaving behind space for the osteoblasts to deposit 
bone matrix.  This process results in a moving front where the cartilage matrix is 
degraded and replaced with woven bone.  The first front originates in the diaphysis, and 
is termed the primary ossification center.  Two other secondary ossification centers form 
at the junction of the diaphysis and epiphysis, forming the growth plate, where the cycle 
of cartilage deposition followed by resorption and bone deposition allows for longitudinal 
growth. 
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Figure 1: Overview of Endochondral Ossification. A) Artistic representation of the various stages of 
bone development through endochondral ossification. Modified from (Mescher, 2009).  B) Image depicting 
the various regions present during the later stages of endochondral ossification.  Stained with Masson 
Trichrome.  Blue regions depict mineralized bone.  Red regions depict cells.  Unstained region in the 
growth plate is the hyaline cartilage template. Modified from (Ortega, Behonick, & Werb, 2004). 
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Muscle & Bone Crosstalk 
It has been known for years that surrounding muscle tissue facilitates bone growth 
and fracture healing.  Surgeons have observed that open tibial fractures heal faster and 
with less complications when surgically repaired and covered with a muscle flap (Harry, 
Sandison, Pearse, Paleolog, & Nanchahal, 2009).  An emerging approach is genetically 
modifying autologous muscle grafts to facilitate fracture repair (Evans et al., 2009).  
Concurrent severe soft tissue trauma has been shown impair fracture callus formation, 
resulting in a delay in fracture healing (Claes et al., 2017).  The Gustilo-Anderson scale is 
used clinically to evaluate the severity of open fractures solely based upon the extent of 
the surrounding soft tissue damage (Kim & Leopold, 2012).  Mechanical forces generated 
by skeletal muscle in utero alter the shape of bone development in order to optimize load 
bearing capacity (Sharir, Stern, Rot, Shahar, & Zelzer, 2011). 
Skeletal muscle and bone are capable of signaling with one another through the 
porous periosteum (Lai, Price, Lu, & Wang, 2014).  During fracture repair, skeletal 
muscle regulates transient inflammation (Abou-Khalil et al., 2014), an important process 
in the recruitment of cells needed for tissue regeneration (Einhorn & Gerstenfeld, 2015).  
Myofibers synthesize osteogenic growth factors including insulin-like growth factor 1 
and fibroblast growth factor 2, which are capable of stimulating osteoprogenitor cells 
through both endocrine and paracrine pathways (Hamrick, 2011).  These observations 
suggest nearby muscle facilitates bone tissue regeneration, although it is unclear whether 
the muscle tissue predominately facilitates bone formation by creating an environment 
conducive to fracture repair, direct mechanical stimulation, local paracrine signaling, 
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directly contributing cells which differentiate into osteogenic cells, or any combination of 
the above.  
 
Muscle trauma and ectopic bone formation 
Heterotopic Ossification (HO) is the aberrant formation of bone tissue in the soft 
tissue of the body including the skin, subcutaneous tissue, skeletal muscle, and blood 
vessels.  There are two forms of HO, the much more prevalent acquired form and the 
rarer genetic form.  Fibrodysplaysia ossificans progressiva (FOP) is the most severe 
genetic form of HO, where extensive HO progressively forms throughout the body, 
eventually resulting in complete immobilization (McCarthy & Sundaram, 2005).  The 
genetic cause of FOP is believed to be due to an upregulation of the bone morphogenic 
protein 4 (BMP-4) signaling pathway, either through the overexpression of BMP-4 
(Shafritz et al., 2009) or a loss of function mutation in noggin, a BMP4 antagonist 
(Sémonin, Fontaine, Daviaud, Ayuso, & Lucotte, 2001). 
 The acquired form of HO is precipitated by trauma including fracture, muscle 
contusion, burns, and orthopedic procedures.  Following total hip arthroplasty, the 
incidence of HO is reported as high as 44% (Rath et al., 2013).  HO is more prevalent 
following polytrauma which includes neurological damage such as spinal cord injury 
(Shehab, Elgazzar, & Collier, 2002), and is seen in more than 20% of patients following 
traumatic brain injury and spinal cord injury (Cipriano, Pill, & Keenan, 2009).  HO is 
also highly prevalent in our military population, where 65% of wounded soldiers who 
suffered blast injuries to an extremity developed HO (Forsberg et al., 2009).  It is not 
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fully understood what mechanisms drive ectopic bone formation in acquired HO.  It is 
believed that dysregulation of BMP signaling plays a crucial role, but other pathways 
including Hedgehog Wnt/ß-catenin, and fibroblast growth factors are also involved (Kan 
et al., 2018).  It is believed the increase in HO prevalence in trauma of the central and 
peripheral nervous system is due to an increase in neuroinflammation that degrades the 
blood-brain and blood-nerve barriers, allowing for the systemic spread of neurohormonal 
osteogenic factors (Davis, Davis, Gugala, & Olmsted-Davis, 2018; Huang et al., 2018). 
HO is a debilitating and painful disease for patients.  Complications of HO 
include nerve impingement, joint ankylosis, pain, and infection (Cipriano et al., 2009).  
The decline in range of motion negatively impacts the patient’s ability to complete 
activities of daily living, decreasing their quality of life.  Due to the lack of mechanistic 
understanding of the cause of HO, there are no effective targeted therapeutic approaches 
to prevent HO in at risk populations.  Treatment guidelines include targeted local 
radiation, bisphosphonates, non-steroidal anti-inflammatory drugs, and allowing the HO 
progress until the ectopic bone develops clean cortical margins that allow for surgical 
excision (Hoyt, Pavey, Potter, & Forsberg, 2018). 
 
Stem Cells 
During both ectopic bone development and fracture repair, multiple populations 
of stem cells are required to proliferate and differentiate into the chondrocytes, 
osteoblasts, and osteoclasts necessary to mineralize and eventually remodel the 
developing bone.  Stem cells are defined as cells that are capable of differentiating into 
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specialized mature cells and self-renewal in order to prevent exhaustion of the stem cell 
pool.  Recently it has emerged that stem cells can vary in their capability to differentiate 
into a variety of specialized cells.  These differences range from the transiently 
pluripotent embryonic stem cell which can differentiate into any cell type in the body, to 
the further differentiated multipotent adult stem cell which can only differentiate into a 
few types of specialized cells or unipotent stem cell populations that give to only one cell 
type (Sánchez Alvarado & Yamanaka, 2014).  The body has multiple types of adult stem 
cells distributed throughout the body, where they reside in their niche and maintain tissue 
function by repairing damage or replenishing cells which are in constant turnover.  The 
classic example is the hematopoietic stem cell that is present within the red bone marrow 
and differentiates to give rise to myelogenous and lymphoid lineages throughout the 
lifetime of the organism (Laurenti & Göttgens, 2018).   
It is interesting to note that recently it has been suggested that some cells may 
transdifferentiate; either cells dedifferentiate and ultimately differentiate toward a 
different lineage or the mature differentiated cell directly differentiates toward a different 
linage. One example of this phenomenon could be the transdifferentiation of hypertrophic 
chondrocytes to osteoblasts during endochondral ossification (L. Yang, Tsang, Tang, 
Chan, & Cheah, 2014). Similarly questions arise concerning the plasticity of various stem 
cell populations which under normal homestatic regeneration have limited capacity to 
differentiate into more than one cell type but on injury gives rise to multiple lineages 
(Debnath et al., 2018). 
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 Adult stem cells from a range of tissue sources contribute to the signaling and 
cellular differentiation events required in fracture repair. Satellite cells from skeletal 
muscle, cells from the endosteum and periosteum, mesenchymal stem cells (MSC) from 
the marrow cavity, and even pericytes from the vascular endothelium have been 
purported to all play a role in fracture repair (Figure 2). 
 
Figure 2: Sources of Stem Cells Involved in Fracture Repair. Above is an illustrated representation of 
the variety of sources of stem cells which contribute to fracture repair.  Shown is a fracture in a long bone 
with the developed fracture callous present.  As previously discussed, note the different methods of bone 
formation; Blue region indicates repair through Endochondral ossification, while taupe indicates 
intramembranous ossification.  Figure from (B. C. Bragdon & Bahney, 2018). 
 
Skeletal Muscle & Satellite Cells 
 Skeletal muscle is a form of striated muscle tissue composed of multinucleated 
contractile myofibers which enable force generation and thus gross and fine skeletal 
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movement.  Over 50 years ago, the satellite cell was discovered on the periphery of 
skeletal muscle myofibers by electron microscopy (Mauro, 1961).  Satellite cells are 
named for their location on the periphery of myofibers, where they are located between 
the sarcolemma and the basal lamina (Mescher, 2009), and can be identified by the 
expression of the paired box transcription factor Pax7 (Seale et al., 2000). 
The skeletal muscle stem cell niche is filled by satellite cells (Figure 3), where 
they are primarily implicated in skeletal muscle regeneration (Yin, Price, & Rudnicki, 
2013).  Similar to other adult stem cells, satellite cells are mitotically quiescent in adult 
muscle and can enter the cell cycle following muscle trauma (Bischoff, 1986; Snow, 
1977).  Not just localized to the site of damage, all of the satellite cells along the same 
myofiber are activated following trauma (Schultz, Jaryszak, & Valliere, 1985).  During 
muscle regeneration, the activated satellite cells are highly mobile, and can migrate  
between myofibers (Hughes & Blau, 1990) and even between muscles (Watt, Morgan, 
Clifford, & Partridge, 1987), regardless of barriers such as the basal lamina.  Satellite 
cells’ capability to repair and regenerate muscle tissue is impressive.  Multiple rounds of 
muscle regeneration can be sustained by transplanting only the satellite cells present on a 
single myofiber to a radiation ablated mouse model (Collins et al., 2005).  While the 
ablation of satellite cells in postnatal animals prevents skeletal muscle regeneration 
following trauma (Lepper, Partridge, & Fan, 2011).   
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Figure 3: The Satellite Cell and it’s Niche.  Above is an image depicting the wide range of signaling 
factors involved in regulating satellite cell’s quiescence, activation, and differentiation.  Note the wide 
range in scope of signaling, from the immediate local association of the satellite cell and its neighboring 
myotube, to androgens circulating in the systemic circulation.  Figure from (Yin et al., 2013).   
 
Skeletal muscle trauma leads to necrosis of the damaged muscle fibers and the 
release of myocyte cytosolic contents into the local milieu.  This includes proteins such 
as creatine kinase, microRNAs and calcium from the sarcoplasmic reticulum, which 
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result in tissue degradation, activation of the complement cascade, and an inflammatory 
response (Yin et al., 2013).  Various factors including Wnt/ß-catenin and Notch signaling 
regulate satellite cell activation.  Following injury, the Notch ligand Delta is upregulated 
on myofibers, and is capable of activating the Notch cascade in satellite cells (Conboy & 
Rando, 2002).  The inflammatory response recruits CD68-/CD163+ macrophages, which 
have been show to promote the proliferation and differentiation of satellite cells (Cantini 
et al., 2002; Lescaudron et al., 1999).  Once activated, satellite cells progress down one of 
either two processes: differentiation or proliferation.  Which process predominates 
depends on the balance in the expression of the transcription factors MyoD and Myf5.  
High MyoD expression causes satellite cells to differentiate towards a myogenic fate, 
whereas high Myf5 expression leads to enhanced proliferation and reduced differentiation 
(Rudnicki, Grand, McKinnell, & Kuang, 2008).    
Satellite cells are also capable of differentiating towards either chondrogenic or 
osteogenic cell lineages.  In the presence of BMP-2, increased levels of the transcription 
factor Sox9 and the repressor Nkx3.2 inhibit the activity of the myogenic transcription 
factor Pax3, resulting in differentiation towards a chondrogenic fate (Cairns et al., 2012).  
Following BMP-2 receptor activation, increased levels of the transcription factor Runx2 
and Smad proteins suppress the activity of myogenic transcription factor MyoD, resulting 
in the differentiation of satellite cells towards osteoblasts (Wada, Inagawa-Ogashiwa, 
Shimizu, Yasumoto, & Hashimoto, 2002). 
Previous research in the lab demonstrated that the Pax7 population of satellite 
cells are not recruited during fracture repair and demineralized bone matrix (DBM)-
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induced ectopic bone in the absence of muscle trauma (Molinelli, 2018).  However, the 
role of muscle trauma has on DBM-induced ectopic bone is unclear and whether trauma-
activated Pax7 cells can contribute to ectopic bone formation. Therefore, the aim of this 
study is to identify whether muscle trauma affects DBM-induced ectopic bone formation 
and how the Pax7 population of cells contribute to this process.  
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SPECIFIC AIMS 
Aim 1: Determine if varying levels of blunt trauma to skeletal muscle had an 
increasing effect on the induction of DBM induced ectopic bone.  Use micro-computed 
tomography to quantify DBM induced ectopic bone volume following different levels of 
muscle trauma generated by varying the drop height of weight driven contusion devise. 
 
Aim 2: Characterize the contribution of the Pax7 satellite cell population to the 
DBM-induced ectopic bone formation with muscle trauma. Use histology to compare the 
recruitment of Pax7 positive satellite to the DBM-induced ectopic bone with or without 
muscle trauma. 
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METHODS 
 
Materials 
Unless otherwise noted, materials and equipment were sourced from Thermo 
Fischer Scientific (Waltham, MA).  Human demineralized bone matrix (Grafton Putty) 
was provided by Medtronics Inc. (Minneapolis, MN). 	
Animals 
Animal studies were approved by the Institutional Animal Care and Use 
Committee at Boston University.  All animals were housed at the BU Animal facilities 
under standard conditions.  Both male and female mice were used.  Pax7tm1(cre/ER2)Gaka/J 
mice were obtained from The Jackson Laboratory (Bar Harbor, ME). The tamoxifen 
inducible Pax7tm1(cre/ER2)Gaka/J transgenic mice were crossed with B6.Cg-
Gt(ROSA)26sor<tm14(CAG-tdTomato)Hze>/J  to create Pax7/Ai14 reporter. These 
animals were subsequently crossed with B6,129S7-Rag1tm1Mom/J mice. This created a 
transgenic reporter mouse that allows for the implantation of human DBM. 
 
Tamoxifen Injections 
Tamoxifen (TMX) was prepared at 10 mg/ml by adding 40 mL of corn oil with 
400 mg of tamoxifen within a chemical safety hood.  To fully solvate the tamoxifen, the 
tamoxifen solution was sonicated in an ice-cold ethanol bath. Multiple rounds of 15 
minutes were completed until tamoxifen was not visible.  The fully dissolved solution 
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was then sterile filtered using an in-line 0.45 µm sterile syringe filter with a 10 ml 
syringe, aliquoted into 2 ml vials, and stored at -80 °C. 
Mice received 2 injections of tamoxifen 48 hours apart.  Injections were delivered 
intraperitoneally with a dose of 10 µL/g of body weight.  Surgery was performed 
following a one-month washout period. 
 
DBM Implant Surgery 
Animals were anesthetized using 4% isoflurane in an anesthesia chamber, and 
then were transferred to a heated operating field where anesthesia was maintained with 
2% isoflurane delivered via a nose cone.  Prior to incision, the mice received 
subcutaneous injections of 0.01 mL of 2.27% Baytril, an antibiotic, and 0.1 mL of 
Buprenex, an analgesic.  The surgical sites were shaved with electric clippers and 
prepped with Betadine.  The DBM (50 mg) was implanted according to (B. Bragdon et 
al., 2017) with the exception that prior to implantation, 0.1 µg of bone morphogenic 
protein 2 (BMP-2) was added to the DBM.  The DBM implant was placed either mid-
shaft against the femoral periosteum or in a pouch created between the medial gluteal and 
femoral quadriceps muscle.  Following DBM implantation surgery, muscle trauma was 
induced with a blow from a blunt dropped mass as described by (Grode, Hardin, & 
Oberfeld, 2017).  The mass was either dropped a total of 31 mm (pin 2) or 71 mm (pin 4) 
in order to change the blunt force, varying the severity of trauma. 
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Harvest & X-ray Imaging 
Mice were harvested at post-operative day (POD) 8 and 16.  Mice were 
euthanized by carbon dioxide inhalation followed by cervical dislocation.  The mice were 
weighed, and a radiograph of each leg was taken to visualize the mineralized ectopic 
tissue using a Faxitron MX-20 Specimen Radiography System (Tucson, AZ) set at 30 kV 
for 40 Seconds.  Denville Scientific HyBlot CL film (Metuchen, NJ) was used.  X-rays 
were developed using a Konica Minolta SRX-101A film processor (Wayne, NJ).  
Femurs were collected and surrounding soft tissue was minimally trimmed to 
avoid accidentally disturbing or removing the ectopic bone implant.  Samples were fixed 
in 4% paraformaldehyde (Sigma-Aldrich, St. Louis, MO) for up to 72-94 hours at 4 °C. 
  
Decalcification 
Following fixation, samples were washed with 1x phosphate-buffered saline 
(PBS) for 10 minutes, three times.  The samples were transferred to Sure-Tek 2 
embedding cassettes and placed in a 1 L Nalgene container and immersed in 14% 
Ethylenediaminetetraacetic Acid (EDTA) (Acros Organics, NJ) and protected from light.   
Samples were decalcified at 4 °C for at least a week with constant stirring.  To measure 
whether decalcification was complete, a 27 ga syringe was used to probe the bone tissue 
checking for resistance and hardness.   
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Frozen Histology 
Once samples were fully decalcified, they were removed from the 14% EDTA 
solution and processed for standard frozen histology.  This consisted of samples being 
washed in increasing concentrations of sucrose.  Samples were incubated for 24 hours in 
7.5% sucrose/PBS solution followed by 24 hours in 30% sucrose/PBS solution.  Samples 
were then incubated overnight in 50% (30% Sucrose)/50% Tissue Plus Optimum Cutting 
Temperature (OCT) compound.  
Samples were embedded by being placed into small plastic molds with OCT.   
While filling the container with OCT, care was taken to avoid air bubbles which would 
disrupt the freezing and ultimately the sectioning process.  A basin containing 2-
Methylbutane was lowered into liquid nitrogen to cool. The plastic container holding the 
sample was then gently lowered into the chilled 2-Methylbutane where it was left to 
freeze for approximately 30 seconds.  Once frozen, the container was removed from the 
liquid nitrogen and the frozen tissue block was freed and stored at -80 °C until sectioned. 
Tissue blocks were sectioned on a Reichert Jung Cryocut 1800 (Wetzlar, Germany) at a 
width of 8-10 µm.  Sections were then mounted on slides and air dried at room 
temperature before being stored at -20 °C.  To prepare fluorescent samples for cover-
slipping, samples were washed with 1x PBS for 5 minutes, twice.  Samples were then 
allowed to air dry and mounted using Molecular Probes Prolong Gold Antifade with 
DAPI.  Air bubbles were carefully removed. 
 
Safranin-O & Fast Green 
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Sections were immersed in Gill number 2 Hematoxylin for 1 minute. Excess 
hematoxylin was removed with 4 dH20 washes.  Sections were transferred to a 0.05% fast 
green solution for 3 minutes followed by 5 dips in 1% acetic acid, and 1 minute 
incubation in 0.2% safranin-O solution.  Sections were air dried and mounted with 
Permount. 
 
Hematoxylin & Eosin Stain 
Sections were stained with Gill’s number 2 Hematoxylin for 2 minutes and rinsed 
with dH2O three times.  Sections were then rinsed in 75% EtOH for 10-15 dips, followed 
by 6-10 dips in Alcoholic Eosin.  Sections were then again rinsed in 75% EtOH for 10 -
15 dips followed by two changes of 95% EtOH, two dips each.  Sections were air dried 
and mounted with Permount. 
 
Goldner’s Trichrome Stain 
 Sections were rehydrated in 70% EtOH for 2 minutes, and then 40% ethanol for 5 
minutes.  Sections were then stained with Weigert’s Hematoxylin for 15 minutes, and 
then rinsed with dH2O until the water was clear, approximately 10 minutes.  Sections 
were then stained in Ponceau Acid fuchsin for 15 minutes and then rinsed with dH2O for 
10 seconds and 1% Acetic Acid for 20 seconds.  Sections were then immersed in 
phosphomolybdic acid-orange G for 6 minutes that was filtered before use, followed by 
rinses in dH2O for 10 seconds and 1% acetic acid for 20 seconds.  Sections were then 
stained with a 0.05% fast green solution for 5 minutes, followed by a wash in dH2O for 
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10 seconds.  Samples were then dehydrated in 70% EtOH for 10 seconds, 95 % EtOH for 
10 and then 30 seconds, and three changes of 100% EtOH for 2 minutes each.  Sections 
were then immersed in two changes of xylene for 2 minutes each.  Sections were air dried 
and mounted with Permount. 
 
Imaging 
Photomicrographs were acquired using an Olympus BX51 microscope (Center 
Valley, PA) fitted with a QiClick image sensor (QImaging, Surrey, BC), and CellSens 
Dimension software (version 1.13, Olympus Corporation).   
Stitched Overview photomicrographs of the large sections were created by 
capturing multiple exposures at a 10x objective using an automated stage and stitched 
together by CellSens software.  Slides prepared for fluorescence were imaged as follows.  
DAPI was imaged with light filtered to 405 nm and an exposure time of 57.82 ms was 
used, and dTomato positive cells were imaged with light filtered to 481 nm and an 
exposure time of approximately 14 ms was used.  Slides prepared for brightfield 
microscopy were imaged with an RGB filter using automatic exposure times. 
 
Micro Computed Tomography 
Samples intended for Micro-Computed Tomography (µCT) analysis were stored 
in 1x PBS at 4 °C after fixation.  Samples were scanned in a 20.5 mm tube filled with 1x 
PBS.  To prevent movement during the scan, the sample was immobilized with low 
density foam packing peanuts.  The loaded samples were then scanned using a SCANCO 
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Medical µCT 40 (SCANCO USA Inc., Wayne, PA) at 70 kVp, 114 µA, medium 
resolution, with an integration time of 200 ms.  The images were manually contoured to 
isolate the DBM implant using SCANCO Medical.  The bone volume (BV) was then 
calculated using a BV script and a threshold of 222.  The threshold was calculated based 
on an average 45% evaluation of the cortical bone intensity from 7 samples.  3D 
renderings were created from the image stacks using 3D Slicer imaging software 
(Fedorov et al., 2012). 
 
Statistical Analysis 
 Statistical analysis and chart creation were accomplished using Microsoft Excel 
(version 16).  The various BVs were compared using t-tests assuming either equal or 
unequal variance between the cohorts. 
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RESULTS  
Determining optimal drop height for ectopic bone with muscle trauma 
 Muscle trauma was created by dropping a weight from a predetermined height 
onto the hind limb.  In a pilot study to determine the optimal drop height for ectopic bone 
formation with muscle trauma, mice were enrolled in either the drop height of 31 mm 
(pin 2) group or 71 mm (pin 4) group.  Previous studies in the lab suggested that different 
forces were applied to the muscle at the different pin settings (Grode et al., 2017). 
Animals received DBM implantation with BMP-2 in either the periosteum or muscle 
tissue alongside the femur followed by muscle trauma.  It should be noted that there was 
increased morbidity with the Pin 4 group compared to the Pin 2 group, and 40% versus 
13% mortality respectively. Plain film radiographs were acquired at post-operative day 
(POD) 16 in order to visualize the presence of mineralized ectopic bone forming in the 
DBM implant.  In figure 4, radiographs of both periosteal and muscle implants from each 
drop height are shown. 
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Figure 4: Effect of Varying Pin Height on DBM Implant.  Above are representative radiographs of both 
periosteal and muscular DBM implants at varying drop heights.  Arrows indicate location of DBM bone 
implants.  All of the above radiographs are of implants that received muscle contusion as indicated by the 
Y-axis, 0.1 µg of BMP-2 at the time of surgery, and were harvested on POD 16. 
 
 
The DBM-induced ectopic bone volume (BV) at the periosteum and muscle 
implant sites were quantified using µCT and compared at the different drop heights 
(Figures 5 and 6).  The ectopic bone at the periosteum with the drop height at pin 2 
resulted in 1.75 mm3 of BV while the drop height at Pin 4 resulted in 1.67 mm3 of BV. 
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The drop height at Pin 2 and Pin 4 did not show a significant difference in BV at the 
periosteal implant site with muscle trauma. The ectopic bone within the muscle, pin 2 
resulted in 0.16 mm3 of BV compared to pin 4 that resulted in 0.006 mm3 of BV.  
Although the muscle implant site with trauma did not show a significant difference, there 
appears to be a trend of increasing BV with the drop height at Pin 2 compared to Pin 4.  	
Figure 5: Effect of Drop Height on Ectopic Bone Volume. All samples were harvested on POD 16, 
received DBM with 0.1 µg of BMP-2 and muscle trauma from drop height at Pin 2 or Pin 4. The left graph 
shows the periosteum ectopic bone volume while the right graph shows the ectopic bone within the muscle.  
In both periosteal and muscle pin 2 groups n=6, and in pin 4 groups n=2. 
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Figure 6: 3D Renderings Demonstrating Effect of Varying Pin Height on Ectopic Bone Volume.  
Above are 3-dimensional renderings of the femur and ectopic bone.  All of the above renderings are of 
samples that received muscle contusion and DBM implant with 0.1 µg of BMP-2 at the time of surgery. 
Tissue was harvested at POD 16. Purple colored regions indicate ectopic bone. Left panels show images 
where the DBM and BMP-2 was implanted on the periosteal surface and the right panels show the DBM 
with BMP-2 implanted within the muscle. Top panels show Pin 2 drop height and lower panels show Pin 4 
drop height.   
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Representative 3-dimensional (3D) renderings of the femur and ectopic bone were 
created in order to visualize the positioning and BV of the implant (Figure 6).  
Qualitatively, these renders correspond with the aforementioned quantitative data in that 
periosteal BV is greater than muscle BV, and that periosteal BVs are similar between pin 
2 and pin 4. 
 
Muscle Trauma Effects Ectopic Bone Formation 
Based on the pilot study, experiments were conducted using the drop height at Pin 
2.  As expected, the periosteal implants induced significantly more BV than muscle 
implants at POD 16, 1.47 mm3 compared to 0.11 mm3 respectively (p < 0.01)(Figure 7).   
 
 
Figure 7: Effect of Tissue Placement on Ectopic Bone Volume. All samples were harvested on POD 16, 
received DBM with 0.1 µg of BMP-2 and muscle trauma from a drop height at pin 2. The periosteum 
ectopic bone was significantly increased compared to the muscle ectopic bone formation (p<0.01), n=6 in 
both periosteum and muscle.  
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During DBM-induced ectopic bone formation, POD 8 is when the chondrogenic 
genes peak while POD 16 is when the osteogenic genes peak (B. Bragdon et al., 2017). 
The progression of ectopic bone formation was then investigated by implanting DBM 
with BMP-2 at the periosteum and within the muscle followed by muscle trauma. Tissue 
was collected at POD 8 and 16.  In both periosteal and muscle implant sites with muscle 
trauma showed increased BV from POD 8 to POD 16 (Figure 8).  However, the increase 
was only significant with the periosteal implant sites with muscle trauma; POD 8 showed 
0.11 mm3 of ectopic bone while at POD 16 1.75 mm3 of ectopic bone developed (p < 
0.01).  The muscle placement of DBM with muscle trauma did show a large variance in 
ectopic BV ranging from 0 to 0.84 mm3. 
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Figure 8: Progression of Mineralized Tissue.  The graph illustrates the difference in ectopic BV between 
the two harvest dates.  All samples received 0.1 µg of BMP-2, and received muscle trauma from a drop 
height of pin 2. Left panel shows BV at the periosteal implant site and right panel shows the muscle 
implant site.  * represents significance p<0.01, POD 8 n=2 and POD 16 n=6. 
 
 
Contribution of Pax7 Cells to Ectopic Bone Formation 
 Satellite cells contribute to muscle regeneration following muscle injury (Yin et 
al., 2013).  The Pax7 can be used to identify this population of satellite cells.  For this 
study, the Pax7/Ai14/Rag inducible reporter animal was used to track the contribution of 
Pax7 cells to the ectopic bone.  Animals received two doses of tamoxifen.   DBM 
implants with or without muscle trauma was then performed one month following 
tamoxifen to allow for the washout of tamoxifen.  Histology was performed on POD 16 
when bone has developed.  Periosteal and muscle placement of DBM implants that did 
not receive skeletal muscle trauma did not show Pax7 derived cells at the site of ectopic 
bone (Figure 9 and 10).  In contrast, muscle injury with either DBM implants within the 
muscle or on the periosteum showed Pax7 derived cells at the ectopic bone site (Figures 
11 and 12 & 13 respectively).  Pax7 positive cells were present in periosteal DBM 
implants following muscle trauma from both pin 2 and pin 4 (Figures 12 and 13). 
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Figure 9: Periosteal DBM Implant with No Muscle Trauma.  Above are photomicrographs from serial 
sections of a periosteal DBM implant from a subject that received no muscle trauma and was harvested on 
POD 16.  Panel A was stained with Hematoxylin, and panel B was stained with DAPI, where blue 
represents nuclei and red represents Pax7 positive cells visualized by dTomato.  A) Overview image 
created by stitching multiple 10x images together. Error bar represents 500 µm. B) 20x images of the 
region bounded in yellow, visualizing the interface between the DBM implant and femur.  Error bar 
represents 100 µm. 
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Figure 10: Muscle DBM Implant with No Muscle Trauma.  Above are photomicrographs from serial 
sections of a skeletal muscle DBM implant from a subject that received no muscle trauma and was 
harvested on POD 16.  Panel A was stained with Hematoxylin, and panel B was stained with DAPI, where 
blue represents nuclei and red represents Pax7 positive cells visualized by dTomato.  A) Overview image 
created by stitching multiple 10x images together. Error bar represents 500 µm. B) 20x images of the 
region bounded in yellow, visualizing the interface between the DBM implant and femur.  Error bar 
represents 100 µm. 
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Figure 11: Skeletal Muscle DBM Implant with Pin 2 Muscle Trauma.  Above are photomicrographs 
from serial sections of a skeletal muscle DBM implant from a subject that received muscle trauma from pin 
2 and was harvested on POD 16.  Panel A was stained with Hematoxylin, and panel B was stained with 
DAPI, where blue represents nuclei and red represents Pax7 positive cells visualized by dTomato.  A) 
Overview image created by stitching multiple 10x images together. Error bar represents 500 µm. B) 20x 
images of the region bounded in yellow, visualizing the interface between the DBM implant and femur.  
Error bar represents 50 µm. 
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Figure 12: Periosteal DBM Implant with Pin 2 Muscle Trauma.  Above are photomicrographs from 
serial sections of a periosteal DBM implant from a subject that received muscle trauma from pin 2, and was 
harvested on POD 16.  Panel A was stained with Hematoxylin, and panel B was stained with DAPI, where 
blue represents nuclei and red represents Pax7 positive cells visualized by dTomato.  A) Overview image 
created by stitching multiple 10x images together. Error bar represents 500 µm. B) 20x images of the 
region bounded in yellow, visualizing the interface between the DBM implant and femur.  Error bar 
represents 100 µm. 
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Figure 13: Periosteal DBM Implant with Pin 4 Muscle Trauma.  Above are photomicrographs from 
serial sections of a periosteal DBM implant from a subject that received muscle trauma form pin 4 and was 
harvested on POD 16.  Panel A was stained with Hematoxylin, and panel B was stained with DAPI, where 
blue represents nuclei and red represents Pax7 positive cells visualized by dTomato.  A) Overview image 
created by stitching multiple 10x images together. Error bar represents 500 µm. B) 20x images of the 
region bounded in yellow, visualizing the interface between the DBM implant and femur.  Error bar 
represents 100 µm. 
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Brightfield microscopy techniques were used to observe morphological changes 
in skeletal muscle, allowing for the visualization of trauma (Figure 14) and potentially the 
resulting regeneration front (Figure 15).  Following trauma, muscle tissue initially is 
degraded through necrosis, and myofibers become enlarged, hypereosinophilic, 
fragmented, vacuolized, and develop pyknotic nuclei, similar to the regions of enlarged 
myofibers in Figure 14 (National Toxicology Program, 2015a).  Following degradation 
via necrosis, satellite cells form new myofibers that can be recognized by their smaller 
diameter and centrally located nuclei, similar to what is seen in Figure 15 (National 
Toxicology Program, 2015b).  The pattern of muscle trauma appears to follow a similar 
pattern of ectopic bone formation within the muscle.  Figure 16 displays 3D renders 
along with a corresponding µCT slices of the sample that responded strongly to the 
muscle contusion.  
Trichrome staining provides stark contrast between skeletal muscle, DBM 
implant, and mineralized and un-mineralized bone (Figure 17) (Gruber, 1992). 
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Figure 14: Skeletal Muscle Trauma.  Above are images of skeletal muscle trauma that was stained with 
hematoxylin and eosin.  A) Overview image created by stitching multiple 10x images together, that 
visualizes a slice of skeletal muscle and the DBM implant (indicated by the arrow).  Scalebar represents 
500 µm.  B) 20x image visualizing the region bounded in blue in A. C) 20x image visualizing the region 
bounded in yellow in A.  Scale bars in both B and C represent 100 µm. 
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Figure 15: Skeletal Muscle Regeneration.  Above are images of a skeletal muscle DBM implant from a 
subject that received muscle trauma from pin 2. A) 10x overview image visualizing the interface between 
skeletal muscle and DBM implant. Section is stained with Fast Green and Safranin-O, dark blue represents 
nuclei.  Scale bar represents 100 µm. B) 40x composite fluorescent image of the region bounded in yellow 
in panel A, visualizing skeletal muscle fibers.  Blue represents nuclei, visualized by DAPI.  Red represents 
Pax7 positive cells visualized by dTomato.  Scale bar represents 20 µm. 
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Figure 16: Strong Responder to Muscle Contusion.  A) 3-dimensional rendering of the femur and 
ectopic bone.  Purple colored regions represent ectopic bone. B) Superior view of the femur and ectopic 
bone alongside the corresponding µCT slice.  Images are of sample that received muscle contusion at Pin 2 
drop height, 0.1 µg of BMP-2 at the time of surgery, and was harvested on POD 16.  This is the same 
sample visualized in Figure 14. 
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Figure 17: Goldner’s Trichrome Stain of a Periosteal DBM Implant. Above are images of a section 
stained with a modified Goldner’s trichrome technique.  Skeletal muscle is bright red, mineralized bone is 
pale green, and unmineralized bone is red (Gruber, 1992). A) Overview image visualizing the femur, 
skeletal muscle, and periosteal DBM implant indicated by the arrow, created by stitching multiple 4x 
images together.  Scale bar represents 500 µm. B) 10x snapshot of the region bounded in yellow in A, that 
visualizes red unmineralized ectopic bone in the DBM implant.  Scale bar represents 100 µm.  Images are 
of sample that received muscle contusion at Pin 2 drop height, 0.1 µg of BMP-2 at the time of surgery, and 
was harvested on POD 16.   
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DISCUSSION 
Effect Muscle Trauma on Ectopic Bone Volume 
 DBM implants placed on the periosteum and in skeletal muscle both induced 
ectopic bone with muscle trauma caused by dropping a weight with pin 2 and pin 4 drop 
heights.  Previous research demonstrated that increasing the drop height of the mass used 
to induce skeletal muscle trauma increases the force and potentially the severity of the 
resulting skeletal muscle trauma (Grode et al., 2017).  At both tissue sites, pin 2 resulted 
in greater BV, though the results were not significantly different compared to Pin 4.  
Muscle trauma caused by pin 4 resulted in an increase in both morbidity and mortality 
compared to pin 2.  The decrease in BV paired with the complications following the 
procedure, suggest that the trauma resulting from the pin 4 drop height may be too 
severe.  Due to the lack of difference between BV across drop heights, the increased 
mortality following trauma from pin 4, and the presence of Pax7 positive cells in the 
implants of both pin 2 and 4, pin 2 appears superior for further investigation. 
Work previously done in the lab demonstrated that DBM implanted on the 
periosteal surface is capable of inducing about 2 mm3 of ectopic bone.  In contrast, 
implantation of DBM within the muscle required 0.3 µg of BMP-2 to induce just 0.23 
mm3 of ectopic bone (Femia, 2013) and a lower amount of BMP-2 (0.1 µg) added to 
DBM implanted within the muscle was not able to induce ectopic bone (data not shown).  
It should be noted that in the current study, a different lot of DBM was used and did not 
induce ectopic bone on the periosteal surface suggesting less inductive ability.  Therefore, 
low levels of BMP-2 (0.1 µg), amounts not capable of inducing ectopic bone alone in the 
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muscle, was added to the DBM to induce ectopic bone.  Although the two studies cannot 
be directly compared, an interesting observation was made.  The implantation of DBM 
with 0.1 µg of BMP-2 within the muscle and trauma induced 0.16 mm3 of ectopic bone.  
The more inductive DBM material with the same amount of BMP-2 in the absence of 
muscle trauma was not able to induce ectopic bone (data not shown).  It is possible that 
the muscle trauma has an additive effect with inducing ectopic bone formation.  This is 
supported by other research which also demonstrates BMP-2 induced ectopic bone 
volume is increased following skeletal muscle trauma, suggesting that skeletal muscle 
trauma results in an environment conducive to ectopic bone formation (Liu et al., 2014). 
 
Effect Muscle Trauma on Pax7 Positive Cell Recruitment 
 Skeletal muscle trauma resulted in the recruitment of Pax7 positive satellite cell 
derived cells to the DBM implant placed both on the periosteum and in skeletal muscle.  
This is in stark contrast to the lack of Pax7 positive derived cells present in both 
periosteal and skeletal muscle DBM implants of the injury free subjects.  While the 
presence of Pax7 positive satellite cell derived cells in both periosteal and skeletal muscle 
DBM implants has been confirmed, it is unclear whether the cells are of a chondrogenic, 
osteogenic, or another lineage.  Further investigation to what lineage and potential 
functional role of the Pax7 positive cells in the DBM implant should be investigated 
further using immunohistochemistry and flow cytometry.  Further investigation into the 
signaling mechanisms and their underpinning genetic controls involved in the recruitment 
and differentiation of the satellite cell to the DBM implants is necessary as well. 
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Limitations 
 One limitation of this study is the small number of subjects enrolled in each 
condition cohort.  The cohort that received skeletal muscle trauma from pin 4 was 
particularly small due to the high mortality following the trauma.  The small number of 
samples in each cohort limited the predictive power of the data, and made it more 
difficult to detect any difference between the cohorts due to the high variance within the 
cohort.  While the small number of subjects limit the power of the study, the intriguing 
presence of Pax7 positive cells in the DBM implants following trauma from Pin 2 drop 
heights, further trials should be conducted at pin 2 alone in order to minimize the harm 
animals are subjected to and confirm the current findings.  In order to more accurately 
characterize the contribution of skeletal muscle trauma, control samples should be 
enrolled with the same lot of DBM and levels of BMP-2 as the current study. 
 This study used Rag1 deficient mice which are incapable of producing mature B 
or T cells, resulting in a severely disrupted adaptive immune system.  Modulation of the 
local inflammatory state has been shown to be critical in muscle regeneration, and CD8+ 
T cells and T regulatory cells have been implicated in this process (W. Yang & Hu, 
2018).  The lack of mature T cells in the mice used in this study may have disrupted or 
delayed skeletal muscle regeneration expected following trauma.  The skeletal muscle 
trauma observed histologically (Figure 14) appears similar to skeletal muscle trauma of 
much earlier time points following injury in other studies (Deane, Gregory, & Mars, 
2013; Hardy et al., 2016).  In order to more accurately observe and characterize skeletal 
muscle trauma, the current experiment should be conducted in mice with functioning 
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adaptive immune systems.  Although, these findings would be confounded by the 
inability to induce ectopic bone formation with human derived DBM due to the likely 
immune reaction. 
 Moving forward, the processing of samples for histology may need to be altered 
to improve the integrity of the skeletal muscle in order to visualize the region which 
received trauma.  The processing protocols used in this study are optimized for bone 
tissue, and differ from those used in the literature to process skeletal muscle.  Improved 
processing will minimize the shrinkage and artifacts present in the muscle tissue, 
allowing for more accurate visualization of the skeletal muscle trauma. 
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